Pembrolizumab-Induced Thyroiditis and Colitis-Presentation and Resolution on Serial FDG PET/CT

Clinical Nuclear Medicine
|September 24, 2020
PubMed
Summary

Immune checkpoint inhibitors like pembrolizumab can cause immune-related adverse events, including thyroiditis and colitis. Discontinuation of pembrolizumab often resolves these inflammatory changes, as seen in this melanoma patient.